Tag: IVL
J&J begins enrolment in pivotal studies evaluating first-of-its-kind carotid IVL platform
Johnson & Johnson (J&J) announced today the initiation of its SKYWARD investigational device exemption (IDE) clinical programme evaluating the novel Shockwave SkyRunner carotid intravascular lithotripsy...
AVS completes US$36 million Series B financing ahead of IVL US...
Amplitude Vascular Systems (AVS) recently announced that it has completed a Series B round of financing of US$36 million. The funding will support the...
AVS and Jacobs Institute partner to study Pulse IVL system
Amplitude Vascular Systems (AVS), developer of the Pulse intravascular lithotripsy (IVL) platform, and the Jacobs Institute, a non-profit medical device innovation centre in Buffalo,...
More research needed but lithotripsy plus TCAR ‘an answer’ in certain...
Earlier this year, researchers debuted single-centre experiences indicating that intravascular lithotripsy (IVL) may be able to expand transcarotid artery revascularisation (TCAR) into patients with...
